| |
| |
|
| Insider
Information: |
Fourteau Patrick |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
69,682 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,927 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
69,682 |
|
|
| Total
Value |
$2,927 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Insys Therapeutics, Inc. |
INSY |
Director |
2017-08-04 |
69,682 |
2013-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2017-08-04 |
4 |
OE |
$1.62 |
$16,200 |
D/D |
10,000 |
69,682 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2017-05-26 |
4 |
OE |
$3.63 |
$36,300 |
D/D |
10,000 |
59,682 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2016-08-11 |
4 |
S |
$18.46 |
$276,900 |
D/D |
(15,000) |
49,682 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2016-03-04 |
4 |
S |
$18.22 |
$273,300 |
D/D |
(15,000) |
64,682 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2015-11-12 |
4 |
S |
$26.48 |
$794,400 |
D/D |
(30,000) |
79,682 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2015-05-27 |
4 |
S |
$60.14 |
$78,844 |
D/D |
(1,311) |
54,841 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2015-05-26 |
4 |
S |
$60.00 |
$287,040 |
D/D |
(4,784) |
56,152 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2015-05-20 |
4 |
S |
$60.00 |
$365,700 |
D/D |
(6,095) |
60,936 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2015-05-19 |
4 |
S |
$60.00 |
$178,140 |
D/D |
(2,969) |
67,031 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2015-03-11 |
4 |
S |
$59.94 |
$599,359 |
D/D |
(10,000) |
70,000 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2014-11-19 |
4 |
S |
$39.11 |
$977,673 |
D/D |
(25,000) |
80,000 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2014-05-15 |
4 |
B |
$22.50 |
$170,775 |
D/D |
7,500 |
105,000 |
2.39 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2013-08-14 |
4 |
B |
$23.77 |
$118,850 |
D/D |
5,000 |
65,000 |
2.39 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2013-05-14 |
4 |
B |
$10.90 |
$54,500 |
D/D |
5,000 |
60,000 |
2.39 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2013-05-13 |
4 |
B |
$11.10 |
$22,200 |
D/D |
2,000 |
55,000 |
2.39 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2013-05-09 |
4 |
B |
$10.75 |
$30,100 |
D/D |
2,800 |
53,000 |
2.39 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2013-05-08 |
4 |
B |
$10.40 |
$2,080 |
D/D |
200 |
50,200 |
2.31 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2013-05-07 |
4 |
B |
$8.00 |
$418,125 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
